home / stock / ipatf / ipatf news


IPATF News and Press, ImmunoPrecise Antibodies Ltd. From 04/09/19

Stock Information

Company Name: ImmunoPrecise Antibodies Ltd.
Stock Symbol: IPATF
Market: OTC

Menu

IPATF IPATF Quote IPATF Short IPATF News IPATF Articles IPATF Message Board
Get IPATF Alerts

News, Short Squeeze, Breakout and More Instantly...

IPATF - TetraGenetics and ImmunoPrecise extend collaboration by signing multi-target service agreement for the Discovery of Therapeutic Antibodies

TetraGenetics and ImmunoPrecise extend collaboration by signing multi-target service agreement for the Discovery of Therapeutic Antibodies Canada NewsWire VICTORIA, April 9, 2019 VICTORIA , April 9, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") ...

IPATF - ImmunoPrecise creates Talem Therapeutics

ImmunoPrecise Antibodies ( OTCQB:IPATF ) has formed a wholly-owned, Cambridge, Massachusetts-based subsidiary, Talem Therapeutics (Talem). More news on: Immunoprecise Antibodies Ltd., Healthcare stocks news, Read more ...

IPATF - ImmunoPrecise Antibodies Leverages Proprietary Technology and Expertise to Create Talem Therapeutics

ImmunoPrecise Antibodies Leverages Proprietary Technology and Expertise to Create Talem Therapeutics Canada NewsWire VICTORIA, April 4, 2019 VICTORIA , April 4, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) a...

IPATF - Monoclonal Antibody Therapy Drug Market on Trajectory Towards $140 Billion

April 4, 2019 New York, NY – April 4, 2019 – Timelines on the next generation of antibody discovery may be getting shorter. Potentially incentivized by a new study on the monoclonal antibody therapy market, analysts recently projected a double-digit 10.5% CAGR by 2022, an...

IPATF - ImmunoPrecise Antibodies Ltd. Announces Trading on OTCQB® Venture Market

ImmunoPrecise Antibodies Ltd. Announces Trading on OTCQB® Venture Market Canada NewsWire VICTORIA, April 3, 2019 VICTORIA , April 3, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce that i...

IPATF - ImmunoPrecise Launches DeepDisplay((TM)) Antibody Discovery Platform

ImmunoPrecise Launches DeepDisplay(™) Antibody Discovery Platform Canada NewsWire VICTORIA, April 2, 2019 ImmunoPrecise Launches Large-Scale Discovery Program with US Pharma Company VICTORIA , April 2, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Compa...

IPATF - ImmunoPrecise Antibodies beats on revenue

ImmunoPrecise Antibodies ( OTCPK:IPATF ): Q3 net loss of $1.2M More news on: ImmunoPrecise Antibodies Ltd., Earnings news and commentary, , Read more ...

IPATF - ImmunoPrecise Antibodies Reports Record Q3 2019 Financials Results

ImmunoPrecise Antibodies Reports Record Q3 2019 Financials Results Canada NewsWire VICTORIA, March 27, 2019 - Revenues Up 228% For The First 9 Months of Fiscal 2019 VICTORIA , March 27, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "ImmunoPrecise") (TSX...

IPATF - Positive Results and New Technology Give Rise to Antibody Dominance

POINT ROBERTS, Wash. and DELTA, British Columbia, March 27, 2019 (GLOBE NEWSWIRE) -- Investorideas.com , a leading investor news resource covering biotech and pharma stocks releases a snapshot looking at the biopharmaceutical market and how monoclonal antibody research is gaining market ...

IPATF - ImmunoPrecise Antibodies Announces Resignation of Jos Raats, as Managing Director of ModiQuest Research BV

ImmunoPrecise Antibodies Announces Resignation of Jos Raats, as Managing Director of ModiQuest Research BV Canada NewsWire VICTORIA, BC, March 15, 2019 VICTORIA, BC , March 15, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OT...

Previous 10 Next 10